IL6 and neoplasm: Ge et al. (Ge et al. 2021a) confirmed that the inflammatory factor interleukin 6(IL-6), released by inflammatory cells or tumor cells, increased OGT expression in lung cancer cells though the NF-κB p65 signaling pathway, leading to migration and invasion.